| Home Market Dynamics Macro Trends Sector Trends Company Insights AI Investing Strategies Sign Up Login |
Sector: Pharmaceuticals
| Bristol-Myers Squibb is successfully navigating revenue declines from legacy products through the introduction and development of new drugs, such as Opdivo. The strength of its drug portfolio, bolstered by promising new products, is a key driver of growth. Strong product performance and development strategies underscore the company's commitment to innovation in the pharmaceutical space. Overall, these factors contribute positively to the company’s stock performance and market resilience. |
| The price action of Bristol-Myers Squibb (BMY) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The trend sentiment at 2 is very bullish. The market sentiment at 0.9 is bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next. BMY is likely to move up since both trend sentiment and market sentiment are positive. The positive sentiment force for sector is at 1.1, and the negative at -0.2 on 2026-07-30. The forces of Stock Price Trend (2), Option Sentiment (1.5), Valuation Sentiment (1.4), Sentiment towards Fundamentals (1.2), Sector Price Trend (0.6), and Market Risk Appetite (0) will drive up the price. The forces of and Price Level Sentiment (-1) will drive down the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
Sign up to reveice notifications on Market Movers
| BMY | ||||||||||||||||
| Date | Attention | Price | StdDev | Price Level | RSI | Hourly RSI | Change | 10 Day Trend | Trend Sentiment | Hourly Trend Sentiment | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-30 | 0%(0%) | 64.87 | 3.58% | 101 | 75 | 62 | 2.79% | 0.65% | 2 | 0.5 | 0.9% | 0.9 | Long | 70% | 1.2 | 2.5 |
| 2026-07-29 | 0%(0%) | 63.11 | 3.45% | 89 | 70 | 18 | -0.84% | 0.65% | 1.6 | -0.3 | 0.8% | 1 | Long | 65% | 1.4 | -1 |
| 2026-07-28 | 0%(0%) | 63.64 | 3.25% | 101 | 73 | 53 | 1.72% | 1.16% | 2.1 | 0.2 | 1.1% | 0.9 | Long | 70% | 1.6 | -1 |
| 2026-07-27 | 0%(0%) | 62.57 | 2.92% | 97 | 68 | 50 | 0.75% | 0.5% | 1.2 | 0 | 0.8% | 0.7 | Wait | 50% | 1.1 | -1 |
| 2026-07-26 | 0%(0%) | 1.6 | 0 | 0.7 | 0.8 | -1 | ||||||||||
| 2026-07-25 | 0%(0%) | 1.6 | 0 | 0.7 | 0.8 | -1 | ||||||||||
| 2026-07-24 | 0%(0%) | 62.1 | 2.72% | 97 | 70 | 64 | 0.93% | 0.84% | 1.6 | 0 | 0.9% | 0.8 | Long | 70% | 1.6 | -1 |
| 2026-07-23 | 0%(0%) | 61.53 | 2.73% | 94 | 62 | 57 | 1.26% | 0.51% | 1.4 | 0 | 0.6% | 0.8 | Long | 55% | 2.1 | -1 |
| 2026-07-22 | 0%(0%) | 60.77 | 2.81% | 88 | 64 | 59 | -0.27% | 0.68% | 1.4 | 0.2 | 0.5% | 1 | Long | 55% | 2 | -1 |
| 2026-07-21 | 0%(0%) | 60.93 | 2.79% | 93 | 60 | 49 | 1.26% | 0.34% | 1.5 | 0.3 | 0.4% | 1 | Long | 55% | 2.2 | -1 |
| Long is the preferred trading strategy with 70% chance of being right. Both trend sentiment and hourly trend are very strong. Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | ||||||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | ||||||||||||||||
| Analysis | ||
| ● Bristol Myers Squibb (BMY) – Equity Research Report Fri. Mar 13, 2026 | ||
| 2026-07-30 17:47:55 New products like Opdivo are playing a critical role in offsetting revenue declines from legacy drugs. |
| 2026-07-30 17:47:55 The drugmaker's decision to lift earnings guidance reflects optimism about new product performance. |
| 2026-07-30 17:47:55 The rising stock price of Bristol Myers Squibb indicates positive investor sentiment despite challenges. |
| 2026-07-30 17:09:33 Analysts express bullish sentiments on the stock's valuation relative to peers, indicating market confidence in future performance. |
| 2026-07-30 17:09:33 The stock price of Bristol-Myers Squibb is rising, reflecting positive market sentiment and investment interest. |
| 2026-07-30 17:09:33 Bristol-Myers Squibb's growth is driven by new and promising drugs, offsetting the decline in legacy products. |
| 2026-07-30 17:09:33 The company raised its guidance for the full year based on strong quarterly results and projections for new drugs. |
| 2026-07-30 17:09:33 Bristol-Myers Squibb reported strong earnings and revenue beats for Q2 2026, showcasing robust financial performance. |
| 2026-07-30 15:50:16 The company faces declining revenue in its legacy drug portfolio, indicating potential concerns. |
| 2026-07-30 15:50:16 New products like Opdivo are helping to offset revenue declines from legacy products. |
| 2026-07-30 15:50:16 The company is increasing its earnings guidance, suggesting confidence in future performance. |
| 2026-07-30 15:50:16 Bristol Myers Squibb's stock has risen, indicating positive investor sentiment despite challenges. |
| 2026-07-30 09:34:15 Despite positive earnings guidance, the stock is experiencing a decline, indicating market skepticism. |
| 2026-07-30 09:34:15 The introduction of new products like Opdivo is helping to offset revenue declines from older products. |
| 2026-07-30 09:34:15 Bristol Myers Squibb is experiencing a decline in revenue from its legacy drug portfolio. |
| 2026-07-30 09:34:15 The company raised its earnings guidance despite challenges, indicating some level of optimism. |